With the approval of the single-dose J&J vaccine, India has five vaccines that have got approval for emergency use. The others are Covishield, Covaxin, Sputnik V and Moderna.
Johnson & Johnson Friday said that it remains committed to bringing the single-dose vaccine and accelerating its availability in India through collaboration with Biological E.
The study, released on bioRxiv, found that J&J’s shot produced roughly five-fold lower levels of antibodies against Delta strain compared to levels raised against an early strain.
J&J said the recipients of its vaccine produced strong neutralising antibodies over the course of at least eight months against all variants, including Delta.
This comes after the US Supreme Court refused to consider J&J’s objections to a 2018 jury finding. The company still faces more than 25,000 lawsuits blaming baby powder for causing cancers.
In late March, workers at a biodefence plant in Baltimore accidentally mixed ingredients of Johnson & Johnson and AstraZeneca vaccines, contaminating 15 million doses.
More than than 8 million Americans have been given J&J’s vaccine, which was haulted after a number of cases of blood clots emerged, especially in young women.
The chipmaker at the heart of the AI revolution may be the most influential stock in Wall Street history. Nvidia has been the primary driver of the market’s gains since the start of 2023.
ISRO’s LMV3 rocket set off the CMS-03 satellite from Sriharikota Sunday. It weighs 4,410 kg, will primarily serve Indian Navy and has a life of at least 15 years.
This world is being restructured and redrawn by one man, and what’s his power? It’s not his formidable military. It’s trade. With China, it turned on him.
COMMENTS